TY - JOUR
T1 - Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury
AU - Singer, Pierre
AU - Theilla, Myriam
AU - Fisher, Haran
AU - Gibstein, Lilly
AU - Grozovski, Elad
AU - Cohen, Jonathan
PY - 2006/4
Y1 - 2006/4
N2 - Objective: To explore the effects of an enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants on the respiratory profile and outcome of patients with acute lung injury. Design: Single-center, prospective, randomized, controlled, unblinded study. Setting: General intensive care department of a tertiary-care, university-affiliated hospital. Patients: A total of 100 patients with acute lung injury, diagnosed according to the American-European Consensus Conference on ARDS. Interventions: Patients were randomized to receive the standard isonitrogenous, isocaloric enteral diet or the standard diet supplemented with EPA and GLA for 14 days. Measurements and Main Results: Patient demographics, Acute Physiology and Chronic Health Evaluation II score, and type of admission were noted at admission. Compared with baseline oxygenation (EPA + GLA group vs. control group), by days 4 and 7, patients receiving the EPA + GLA diet showed significant improvement in oxygenation (PaO2/FIO2, 317.3 ± 99.5 vs. 214.3 ± 56.4 and 296.5 ± 165.3 vs. 236.3 ± 79.8, respectively; p < .05). Compliance was significantly higher in the EPA + GLA group observed at day 7 (55.1 ± 46.5 vs. 35.2 ± 20.0 mL/mbar, p < .05). No significant difference was found in nutritional variables. Resting energy expenditure was significantly higher in patients in the EPA + GLA group, but their body mass index was also higher (p < .05). A significant difference was found in length of ventilation (p < .04) in favor of the EPA + GLA group. There was no between-group difference in survival. Conclusions: In patients with acute lung injury, a diet enriched with EPA + GLA may be beneficial for gas exchange, respiratory dynamics, and requirements for mechanical ventilation.
AB - Objective: To explore the effects of an enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants on the respiratory profile and outcome of patients with acute lung injury. Design: Single-center, prospective, randomized, controlled, unblinded study. Setting: General intensive care department of a tertiary-care, university-affiliated hospital. Patients: A total of 100 patients with acute lung injury, diagnosed according to the American-European Consensus Conference on ARDS. Interventions: Patients were randomized to receive the standard isonitrogenous, isocaloric enteral diet or the standard diet supplemented with EPA and GLA for 14 days. Measurements and Main Results: Patient demographics, Acute Physiology and Chronic Health Evaluation II score, and type of admission were noted at admission. Compared with baseline oxygenation (EPA + GLA group vs. control group), by days 4 and 7, patients receiving the EPA + GLA diet showed significant improvement in oxygenation (PaO2/FIO2, 317.3 ± 99.5 vs. 214.3 ± 56.4 and 296.5 ± 165.3 vs. 236.3 ± 79.8, respectively; p < .05). Compliance was significantly higher in the EPA + GLA group observed at day 7 (55.1 ± 46.5 vs. 35.2 ± 20.0 mL/mbar, p < .05). No significant difference was found in nutritional variables. Resting energy expenditure was significantly higher in patients in the EPA + GLA group, but their body mass index was also higher (p < .05). A significant difference was found in length of ventilation (p < .04) in favor of the EPA + GLA group. There was no between-group difference in survival. Conclusions: In patients with acute lung injury, a diet enriched with EPA + GLA may be beneficial for gas exchange, respiratory dynamics, and requirements for mechanical ventilation.
KW - Acute lung injury
KW - Antioxidants
KW - Borage oil
KW - Enteral feeding
KW - Fish oil
KW - Mechanical ventilation
UR - http://www.scopus.com/inward/record.url?scp=33645813176&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000206111.23629.0A
DO - 10.1097/01.CCM.0000206111.23629.0A
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 16484911
AN - SCOPUS:33645813176
SN - 0090-3493
VL - 34
SP - 1033
EP - 1038
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 4
ER -